CEO of Meridian Bioscience Inc (30-Year Financial, Insider Trades) John P. Kenny (insider trades) bought 30,000 shares of VIVO on 03/12/2020 at an average price of $5.78 a share. The total cost of this purchase was $173,400.
Meridian Bioscience Inc is an integrated life science company. It is engaged in development, manufacture, sale and distribution of diagnostic test kits for certain gastrointestinal, viral, respiratory and parasitic infectious diseases. Meridian Bioscience Inc has a market cap of $255.260 million; its shares were traded at around $5.96 with a P/E ratio of 12.96 and P/S ratio of 1.30. The dividend yield of Meridian Bioscience Inc stocks is 2.09%. GuruFocus has detected 3 severe warning signs with Meridian Bioscience Inc. .
CEO Recent Trades:
- CEO John P. Kenny bought 30,000 shares of VIVO stock on 03/12/2020 at the average price of $5.78. The price of the stock has increased by 3.11% since.
- CEO John P. Kenny bought 10,000 shares of VIVO stock on 02/21/2020 at the average price of $7.65. The price of the stock has decreased by 22.09% since.
CFO Recent Trades:
- Exec VP & CFO Bryan T Baldasare bought 2,000 shares of VIVO stock on 03/10/2020 at the average price of $6.97. The price of the stock has decreased by 14.49% since.
Directors and Officers Recent Trades:
- Director John Mcilwraith bought 5,000 shares of VIVO stock on 02/25/2020 at the average price of $7.59. The price of the stock has decreased by 21.48% since.
- Director John Mccune Jr. Rice bought 3,000 shares of VIVO stock on 02/24/2020 at the average price of $7.52. The price of the stock has decreased by 20.74% since.
For the complete insider trading history of VIVO, click here
.
